TGRX-326

targets ALK via inhibition

Developed for

non-small cell lung carcinoma

Investigated by

Shenzhen TargetRx Co., Ltd. · Sun Yat-sen University Cancer Center · The First Affiliated Hospital of Bengbu Medical University · Affiliated Cancer Hospital of Guizhou Medical University · Bingzhou Medical University Affiliated Hospital · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

+32 more

· Capital Medical School Beijing Chest Hospital · First Affiliated Hospital Xi'an Jiaotong University · First Affiliated Hospital, Sun Yat-Sen University · First Hospital of China Medical University · Fujian Cancer Hospital · Haerbin Medical University Cancer Hospital · Henan Cancer Hospital · Hunan Cancer Hospital · Jiangxi Provincial Cancer Hospital · Jilin Provincial Tumor Hospital · Jingzhou First People's Hospital · Liaoning Cancer Hospital & Institute · Mianyang Central Hospital · Nanchang University First Affiliated Hospital · Ningbo No. 1 Hospital · Shandong Cancer Hospital and Institute · Shanghai Chest Hospital · Shijiazhuang People's Hospital · Sichuan Cancer Hospital and Research Institute · The Affiliated Hospital of Qingdao University · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · The First Affiliated Hospital of Soochow University · The First Affiliated Hospital of Zhengzhou University · The Second Affiliated Hospital of AFMU · Tianjin Cancer Hospital · Tongji Hospital · West China Hospital · Xiangyang Central Hospital · Xinxiang Central Hospital · Yunnan Cancer Hospital · Zhejiang Cancer Hospital · Zhejiang University